blood sugar
19 interactions related to blood sugar
tirzepatide + insulin
Tirzepatide lowers blood sugar, but on its own it rarely causes a dangerous low because it only prompts insulin release when blood sugar is already raised. insulin does not work that way — it drives insulin regardless of the current level. Combined, the glucose-lowering adds up and blood sugar can fall too far, and eating less on Tirzepatide removes the buffer that would normally protect against it. Every FDA label in this class carries the same instruction.
semaglutide + insulin
Semaglutide lowers blood sugar, but on its own it rarely causes a dangerous low because it only prompts insulin release when blood sugar is already raised. insulin does not work that way — it drives insulin regardless of the current level. Combined, the glucose-lowering adds up and blood sugar can fall too far, and eating less on Semaglutide removes the buffer that would normally protect against it. Every FDA label in this class carries the same instruction.
liraglutide + insulin
Liraglutide lowers blood sugar, but on its own it rarely causes a dangerous low because it only prompts insulin release when blood sugar is already raised. insulin does not work that way — it drives insulin regardless of the current level. Combined, the glucose-lowering adds up and blood sugar can fall too far, and eating less on Liraglutide removes the buffer that would normally protect against it. Every FDA label in this class carries the same instruction.
semaglutide + glipizide
Semaglutide lowers blood sugar, but on its own it rarely causes a dangerous low because it only prompts insulin release when blood sugar is already raised. a sulfonylurea such as glipizide does not work that way — it drives insulin regardless of the current level. Combined, the glucose-lowering adds up and blood sugar can fall too far, and eating less on Semaglutide removes the buffer that would normally protect against it. Every FDA label in this class carries the same instruction.
tirzepatide + glipizide
Tirzepatide lowers blood sugar, but on its own it rarely causes a dangerous low because it only prompts insulin release when blood sugar is already raised. a sulfonylurea such as glipizide does not work that way — it drives insulin regardless of the current level. Combined, the glucose-lowering adds up and blood sugar can fall too far, and eating less on Tirzepatide removes the buffer that would normally protect against it. Every FDA label in this class carries the same instruction.
liraglutide + glipizide
Liraglutide lowers blood sugar, but on its own it rarely causes a dangerous low because it only prompts insulin release when blood sugar is already raised. a sulfonylurea such as glipizide does not work that way — it drives insulin regardless of the current level. Combined, the glucose-lowering adds up and blood sugar can fall too far, and eating less on Liraglutide removes the buffer that would normally protect against it. Every FDA label in this class carries the same instruction.
mk-677 + insulin
MK-677 raises growth hormone, and growth hormone reduces the body's sensitivity to insulin. Across multiple controlled trials this shows up as rising fasting blood sugar and rising HbA1c. In a two-year randomised trial, sixteen of forty-three participants taking MK-677 crossed into the impaired fasting glucose range, against two of twenty-two on placebo, and insulin sensitivity fell measurably. A more recent six-month trial saw HbA1c rise significantly, with two of thirteen participants stopping because of high blood sugar. This works directly against what insulin is prescribed to do.
mk-677 + metformin
MK-677 raises growth hormone, and growth hormone reduces the body's sensitivity to insulin. Across multiple controlled trials this shows up as rising fasting blood sugar and rising HbA1c. In a two-year randomised trial, sixteen of forty-three participants taking MK-677 crossed into the impaired fasting glucose range, against two of twenty-two on placebo, and insulin sensitivity fell measurably. A more recent six-month trial saw HbA1c rise significantly, with two of thirteen participants stopping because of high blood sugar. This works directly against what metformin is prescribed to do.
alcohol + glipizide
Alcohol can potentiate the glucose-lowering effect of glipizide and, rarely, provoke a disulfiram-like flushing reaction; the main risk is prolonged hypoglycemia.
metformin + alpha-lipoic acid
Metformin and alpha-lipoic acid both lower blood glucose by independent routes, so their effects can be additive. The added effect is mild for most people, but matters more in those also taking insulin or a sulfonylurea, or who are elderly, thin, or on a beta-blocker.
metformin + chromium
Chromium is sometimes taken to support blood sugar, and in theory it could add to metformin's glucose-lowering effect. In practice, human trials are mixed: some show a small improvement in insulin sensitivity while most show little or no change in actual blood glucose. The combination is generally well tolerated, but because both are aimed at the same goal, it is worth flagging to your prescriber and watching for any signs of a low.
glipizide + berberine
Berberine lowers blood sugar on its own and also slows the breakdown of glipizide by inhibiting the liver enzyme CYP2C9. Taken together, the two effects can stack and increase the risk of low blood sugar (hypoglycemia), which with a sulfonylurea like glipizide can be prolonged. Do not combine them without prescriber supervision.
metformin + cinnamon
Cinnamon has a mild glucose-lowering effect that can add modestly to metformin's. In pooled human trial data the effect on fasting glucose is small and there are no reports of serious low blood sugar from the combination, so the practical concern is minor for most people. The main extra consideration is choosing the lower-coumarin Ceylon variety for long-term daily supplement use.
glipizide + bitter melon
Bitter melon (Momordica charantia) has its own blood-sugar-lowering activity through several mechanisms, including enhanced glucose uptake into muscle and possible effects on insulin secretion. Combined with the sulfonylurea glipizide, the effects can add together and push blood sugar too low, with the greatest risk after meals and in higher-risk patients.
psyllium + metformin
Psyllium's viscous gel can slow and reduce metformin absorption when taken together, potentially blunting its glucose-lowering effect, while psyllium's own action lowers glucose — making net blood-sugar effects variable.
glucomannan + metformin
Glucomannan is a highly viscous soluble fiber that swells in the gut and can slow or reduce the absorption of medications taken at the same time, including metformin. Glucomannan also has its own modest glucose-lowering effect that may add to metformin's, so spacing the two apart and watching your blood sugar is sensible.
smoking + insulin
Smoking worsens insulin resistance through nicotine-driven catecholamine release, oxidative stress, and inflammation, and slows subcutaneous insulin absorption through vasoconstriction, so people with diabetes who smoke typically need more insulin to reach the same glucose control. Quitting improves insulin sensitivity within days to weeks, so insulin doses often need to come down to avoid hypoglycemia.
ginger tea + metformin
Ginger (Zingiber officinale) has modest blood-glucose-lowering activity in randomized trials in type 2 diabetes, mainly improving fasting glucose and HbA1c. Combined with metformin the effect is generally additive rather than dangerous. Metformin alone rarely causes hypoglycemia, so the practical concern is small; the risk of a true low rises mainly when ginger is layered onto insulin or an insulin-secreting drug.
alcohol + insulin
Alcohol suppresses the liver's production of new glucose (gluconeogenesis), removing a key safety net against low blood sugar, while insulin lowers glucose directly. Combined, they can cause severe, prolonged, and delayed hypoglycemia, especially when drinking on an empty stomach or in the evening.